Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medtronic PLC (MDT) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance

Medtronic PLCTrade
Consumer Staples Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Medtronic PLC vs Consumer Staples Select Sector SPDR Fund — how do they compare? Medtronic PLC trades at $87.75 (market cap $112.24B), while Consumer Staples Select Sector SPDR Fund trades at $83.22 (market cap $13.50B). The key difference: Medtronic PLC is far larger — about 8.3× Consumer Staples Select Sector SPDR Fund's market cap, and Medtronic PLC pays a 3.28% dividend while Consumer Staples Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Consumer Staples Select Sector SPDR Fund for 72 Days on average.

MDTXLP
Market Cap
$112.24B$13.50B
Volume
105,663,23614,599,953
Sector
Health—
52-Week High
$105.35$90.00
52-Week Low
$73.75$75.61
Typical Hold Time
63 Days72 Days
Enterprise Value
$131.58B—
Dividend Yield
3.28%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medtronic PLC

Medtronic (MDT) trades at $85.51, down 1.81% on the day, with the stock showing bearish technical signals despite strong fundamental performance. The company has beaten earnings expectations for three consecutive quarters, maintains a healthy 13.93% net income margin, and offers a solid 3.2% dividend yield with 49 consecutive years of dividend growth. Recent positive developments include FDA clearances for new medical technologies and raised full-year guidance.

MDT presents a compelling value opportunity with analyst consensus pointing to 14% upside to the $97.80 price target. The stock's current valuation multiples (P/E 21.61, P/S 3.01) appear reasonable given the company's stable revenue growth and strong cash flow generation. Key risks include increasing debt levels and competitive pressures in the medical device sector, but the company's dividend aristocrat status and improving operational performance support a positive long-term outlook.

Consumer Staples Select Sector SPDR Fund

XLP trades at $81.70, showing slight weakness with a 0.09% decline amid bearish technical signals. The ETF maintains strong analyst support with a 100% buy rating from 2 analysts, though technical indicators show moving averages and overall signals are bearish. Recent news highlights XLP's defensive characteristics and competitive expense ratio advantage over peers.

The consumer staples ETF offers defensive exposure during market volatility, supported by positive sector performance in 2026. Key risks include interest rate sensitivity and potential consumer spending slowdowns. Analyst consensus remains bullish despite technical headwinds, positioning XLP as a core defensive holding.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MDT
53% Buy47% Sell
Avg holding period · 63 Days
XLP
100% Buy0% Sell
Avg holding period · 72 Days

Top news

Latest headlines on both assets

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT →

About Consumer Staples Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.

Read more on XLP →